Colloidal bismuth pectin granules
Term · Oncology and biomedicine · MLC-T-ONC-012705
A granule-based formulation containing colloidal bismuth pectin (CBP), with potential cytoprotective activities. Upon oral administration of the colloidal bismuth, bismuth inhibits peptic activity, increases mucosal secretions of prostaglandins and bicarbonate and acts as a barrier to prevent damage by acids. It also prevents adhesion of Helicobacter (H.) pylori to epithelial cells and can inhibit enzymes secreted by H. pylori. This protects against ulcer formation and may help heal existing ulcers.
| Identifier | MLC-T-ONC-012705 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | bismuth colloidal pectin granules; CBP granules |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012705",
"term": "Colloidal bismuth pectin granules",
"field": "Oncology and biomedicine",
"definition": "A granule-based formulation containing colloidal bismuth pectin (CBP), with potential cytoprotective activities. Upon oral administration of the colloidal bismuth, bismuth inhibits peptic activity, increases mucosal secretions of prostaglandins and bicarbonate and acts as a barrier to prevent damage by acids. It also prevents adhesion of Helicobacter (H.) pylori to epithelial cells and can inhibit enzymes secreted by H. pylori. This protects against ulcer formation and may help heal existing ulcers.",
"synonyms": [
"bismuth colloidal pectin granules",
"CBP granules"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/colloidal-bismuth-pectin-granules/"
}
Record 5,100 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.